Predicted LncRNA

DataTables

LncRNA Compound Cancer P-value Effect
ENSG00000261595.1 ABT-263 (navitoclax) Lung squamous cell carcinoma 0.036428831 Resistant
ENSG00000261595.1 ABT-263 (navitoclax) Skin cutaneous melanoma 0.017989821 Resistant